By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Capricor Therapeutics, Inc. 

8700 Beverly Boulevard
Davis Building - Room D-1063
Los Angeles  California  90048  U.S.A.
Phone: n/a Fax: n/a



Company News
Capricor Therapeutics, Inc. Announces Acquisition Of Intellectual Property Rights To Family Of Natriuretic Peptides From Medtronic, Inc. (MDT) 10/14/2014 7:13:45 AM
Capricor Therapeutics, Inc. Announces Plans To Pursue A Cenderitide Clinical Program And Enters Into Research Support Agreement With Insulet Corporation (PODD) 10/9/2014 8:10:58 AM
Capricor Therapeutics, Inc. Announces Plans To Pursue Clinical Program For The Treatment Of Duchenne Muscular Dystrophy With Cardiosphere-Derived Cells (CDCs) 10/6/2014 7:25:48 AM
Capricor Therapeutics, Inc. Presents Safety And Preliminary Efficacy Results From ALLSTAR Phase I Clinical Trial At TCT 2014 9/18/2014 7:47:07 AM
Capricor Therapeutics, Inc. Reports Second Quarter 2014 Financial & Business Highlights 8/13/2014 12:32:26 PM
Capricor Therapeutics, Inc. To Hold Second Quarter 2014 Business Update Conference Call On August 13, 2014 At 4:30 P.M. Eastern Time 8/4/2014 8:21:03 AM
Capricor Therapeutics, Inc. Announces Encouraging Results From Phase1 ALLSTAR Trial; Phase 2 Trial Underway 7/16/2014 6:07:12 AM
Capricor Therapeutics, Inc. To Present At The First Regenerative Medicine Forum At Biotechnology Industry Organization (BIO) International Convention 6/23/2014 10:53:06 AM
Capricor Therapeutics, Inc. Speaks At Panel On Regulation Of Stem Cell-Derived Therapeutic Products At Drug Information Association 2014 50th Annual Meeting 6/20/2014 8:35:13 AM
Capricor Therapeutics, Inc. To Present On Exosomes As A Basis For Innovative Platform Technology At 11th International Symposium On Stem Cell Therapy And Cardiovascular Innovations 5/29/2014 9:29:37 AM